The FDA has approved Saphnelo (anifrolumab-fnia) for subcutaneous administration in patients with systemic lupus ...
Safe injection practices are essential for protecting both patients and healthcare providers from preventable harm. From proper site selection and aseptic preparation to correct disposal, mastering ...